Verified Treatment Center
Evergreen Treatment Center Bergen New Bridge Medical Center
Paramus, NJ · 07652
Key Takeaways for Evergreen Treatment Center Bergen New Bridge Medical Center
- • Detox · Inpatient · IOP · MAT offered
- • Accepts Medicaid, Medicare, Private insurance
- • Joint Commission accredited · SAMHSA-listed facility
- • Direct line available · Helpline free & confidential 24/7
About Evergreen Treatment Center Bergen New Bridge Medical Center
Evergreen Treatment Center Bergen New Bridge Medical Center (Paramus, NJ) is a SAMHSA Behavioral Health Treatment Services Locator-registered facility. The facility offers a continuum of care across multiple levels — Detox, Inpatient, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. Evaluation of this facility against current clinical standards should encompass ASAM 4e framework alignment, MAT policy, and payer-specific network status.
Care levels at Evergreen Treatment Center Bergen New Bridge Medical Center
The facility offers a continuum of care across multiple levels — Detox, Inpatient, IOP, MAT — which means it can, in principle, hold a patient across the arc of a typical treatment episode. The practical question is whether it is genuinely strong at each level, or whether one level is the core business and the others are secondary. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of Evergreen Treatment Center Bergen New Bridge Medical Center's offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.
Insurance and payment
Payment and insurance posture: Evergreen Treatment Center Bergen New Bridge Medical Center accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. Pre-admission Verification of Benefits (VOB) documentation should include: specific plan product and network status, deductible status at time of admission, coinsurance rate applicable, prior authorization status and turnaround, and out-of-pocket accumulation. Under MHPAEA 2024 disclosure rules, plan-specific medical-necessity criteria must be available on request.
Specialty programming
The facility's documented specialty programming includes: Adolescents, Clients with co-occurring mental and substance use disorders. Clinical verification of specialty programming should encompass credentialed staff profile, programming-hour documentation, and specialty-specific medical-necessity documentation for third-party authorization. The MHPAEA 2024 rule addresses specialty-program network adequacy for patients requiring specific clinical capabilities.
Before you call
Pre-admission documentation for Evergreen Treatment Center Bergen New Bridge Medical Center should include ASAM-framework level-of-care justification, plan-specific Verification of Benefits with network-contract confirmation, written MAT policy for opioid use disorder patients where applicable, and licensure/accreditation verification. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.
Listing sourced from the SAMHSA Behavioral Health Treatment Services Locator. Data last synced April 2026. Verify current programs directly with the facility.
Evergreen Treatment Center Bergen New Bridge Medical Center at a Glance
Levels of care
Detox · Inpatient · IOP · MAT
Service settings
Hospital inpatient/24-hour hospital inpatient, Outpatient, Hospital inpatient detoxification, Hospital inpatient treatment, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Therapy approaches
Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling
Age groups
Children/Adolescents
Special populations
Adolescents, Clients with co-occurring mental and substance use disorders
Medications
Acamprosate (Campral®), Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine (extended-release, injectable), Naltrexone (extended-release, injectable)
Insurance & Payment Accepted
Confirm in-network status before admission — verification is free.
Medicaid
Coverage details →Medicare
Coverage details →Private insurance
Coverage details →TRICARE / VA
Contact & Location
Address
230 East Ridgewood Avenue, Paramus, NJ 07652
Facility direct line
201-967-4189Website
www.newbridgehealth.org